Jyothika Mamadgi, MD

Ramzi F. Khalil, MD is an interventional cardiologist with AHN Cardiovascular Institute, skilled at cardiac catheterization, coronary angioplasty, and carotid artery stent. He provides patient-centered care for structural heart disease and peripheral artery disease. Dr. Khalil went to medical School at American University of Beirut School of Medicine in Beirut, Lebanon. He did his residency at Cleveland Clinic in Cleveland, Ohio and his fellowship in cardiology and interventional cardiology at AHN General Hospital and AHN West Penn Hospital in Pittsburgh, Pennsylvania. He is certified by the American Board of Internal Medicine in Cardiovascular Disease and Interventional Cardiology. Dr. Khalil speaks English, Arabic, and French, and sees patients ages 18 and older.

AHN Surgery in Kittanning, PA, offers a comprehensive range of surgical services, specializing in areas such as cancer treatment, cardiovascular care, and burn prevention. The facility is equipped with advanced technology and a team of dedicated professionals committed to providing quality care and reassurance to their patients. In addition to traditional surgical options, AHN Surgery emphasizes integrated care models, including telehealth services, to enhance patient accessibility and convenience. Their focus on innovative treatments and patient support ensures a holistic approach to health and wellness. Generated from the website

Dr. Bailey is Chair of the Allegheny Health Network Cardiovascular Institute and System Chair of the AHN Department of Thoracic and Cardiovascular Surgery. Dr. Bailey is also an Associate Professor of Cardiothoracic Surgery, Drexel University College of Medicine and the first recipient of the Magovern Endowed Chair in Cardiothoracic Surgery. He has expertise in complex heart surgery, aortic aneurysm surgery, minimally invasive valve repair and percutaneous valve surgery, heart transplantation and mechanical circulatory support, and re-operative cardiac surgery. He is also skilled at complex surgery for high-risk patients, allowing these patients to get the care they need. He takes special interest in providing second opinions, particularly for patients previously turned down for surgery. Dr. Bailey’s research has been widely published, focusing broadly on optimizing clinical, technological, and economic outcomes of complex cardiac procedures. As a primary investigator (PI) in medical research, he has been involved in several national clinical trials that have contributed to FDA approval and widespread clinical use of devices, such as the Thoratec HeartMate II and III, as well as the HVAD Lateral trial demonstrating safety and efficacy of minimally invasive LVAD implantation. He also was the PI on the Partner 3 trial, a landmark for demonstrating superior outcomes for TAVR in low-risk patients. He earned his medical degree from Vanderbilt University in Nashville, Tennessee. He completed his general surgery residency at the University of Utah, Salt Lake City, Utah, and his cardiothoracic surgery residency at Columbia University, New York Presbyterian Hospital in New York City. He is certified by the American Board of Thoracic Surgery and American Board of Surgery. He is a member of the American College of Surgeons, American Heart Association, Society of Thoracic Surgeons, and International Society for Heart and Lung Transplantation.